Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Diffusion Pharmaceuticals Inc | DFFN | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 4,40 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 4,40 | 4,40 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 4,14 - 7,785 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | US$ 4,40 | USD |
Finanzwerte DFFN
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 24,97M | 5,68M | - | 7,15M | -2,17M | -0,38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Diffusion Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 23.4.2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12.4.2024 | 01:55 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 05.4.2024 | 22:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04.4.2024 | 13:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 29.3.2024 | 21:02 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 28.3.2024 | 13:36 | Edgar (US Regulatory) | Form 8-K - Current report |
| 18.3.2024 | 21:32 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.3.2024 | 22:05 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 05.3.2024 | 14:51 | Edgar (US Regulatory) | Form 8-K - Current report |
| 28.2.2024 | 23:02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 14.2.2024 | 15:23 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 09.2.2024 | 23:02 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial.. |
Forum Diffusion Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
DFFN Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Jahr | 5,64 | 7,785 | 4,14 | 5,75 | 13.666 | -1,24 | -21,99% |
| 3 Jahre | 1,0833 | 14,025 | 0,249 | 0,950581 | 580.195 | 3,32 | 306,17% |
| 5 Jahre | 5,01 | 14,025 | 0,249 | 1,36 | 1.845.719 | -0,61 | -12,18% |
